Search

David Clay Phones & Addresses

  • Easton, PA
  • Huntingdon Valley, PA
  • 1151 Butler St, Easton, PA 18042 (610) 316-3814

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Graduate or professional degree

Professional Records

Medicine Doctors

David Clay Photo 1

David W. Clay

View page
Specialties:
Internal Medicine
Education:
Medical School
University of Arkansas College of Medicine at Little Rock
Graduated: 1992
Procedures:
Cardiac Stress Test
Continuous EKG
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Pulmonary Function Tests
Vaccine Administration
Conditions:
Acute Bronchitis
Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections
Alopecia Areata
Description:
Dr. Clay graduated from the University of Arkansas College of Medicine at Little Rock in 1992. He works in Fayetteville, AR and specializes in Internal Medicine. Dr. Clay is affiliated with Northwest Medical Center and Washington Regional Medical Center.

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Clay
Proprietor
LITTLE BUILDINGS FINE SCALE MODELS
Architects
2872 Inez Drive, Victoria, BC V9A 2J1
(250) 383-1793, (250) 383-1799
David W. Clay
Director
Grace Baptist Church of Odessa
David Clay
Proprietor
LITTLE BUILDINGS FINE SCALE MODELS
Architects
(250) 383-1793, (250) 383-1799
David L Clay
GLENCOE PROPERTIES, LTD
David L. Clay
POP AND MOM CULTURE, LLC
David A. Clay
SELECT CONSTRUCTION, INC
David D. Clay
TOTAL TOOLING, INC
David Clay
CLAY IMPRINTS LTD

Publications

Us Patents

Hemocompatibility Modifiers For Cross-Linked Polymeric Material

View page
US Patent:
20210402075, Dec 30, 2021
Filed:
May 6, 2021
Appl. No.:
17/313424
Inventors:
- Monmouth Junction NJ, US
Vincent J. Capponi - Lawrenceville NJ, US
David R. Clay - West Orange NJ, US
International Classification:
A61M 1/36
A61M 1/34
A61M 1/02
B01J 20/28
B01J 20/32
A01N 1/02
B01J 20/26
Abstract:
The invention concerns methods of removing undesirable molecules from the blood or physiologic fluid; said method comprising contacting said blood or physiologic fluid with a sorbent, said sorbent comprising a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of ligands attached to the surface of said cross-linked polymeric material, comprising (i) zwitterionic moieties, (ii) oligo(ethylene glycol) moieties or (iii) mixtures thereof; said contacting comprising said sorbent sorbing a plurality of said undesirable molecules when said sorbent is administered within a patient's body.

Hemocompatibility Modifiers For Cross-Linked Polymeric Material

View page
US Patent:
20200246532, Aug 6, 2020
Filed:
Apr 17, 2020
Appl. No.:
16/851305
Inventors:
- Monmouth Junction NJ, US
Vincent J. Capponi - Lawrenceville NJ, US
David R. Clay - West Orange NJ, US
International Classification:
A61M 1/36
A61M 1/34
B01J 20/32
B01J 20/26
A01N 1/02
B01J 20/28
A61M 1/02
Abstract:
The invention concerns methods of removing undesirable molecules from the blood or physiologic fluid; said method comprising contacting said blood or physiologic fluid with a sorbent, said sorbent comprising a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of ligands attached to the surface of said cross-linked polymeric material, comprising (i) zwitterionic moieties, (ii) oligo(ethylene glycol) moieties or (iii) mixtures thereof; said contacting comprising said sorbent sorbing a plurality of said undesirable molecules when said sorbent is administered within a patient's body.
David Clay from Easton, PA Get Report